Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)

NCT01983241 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

345

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Emphysema in Alpha-1 PI Deficiency

Interventions

BIOLOGICAL: Alpha-1 MP
OTHER: 0.9% Sodium Chloride for Injection, USP

Sponsor

Grifols Therapeutics LLC